What is the current stock price of Icosavax, Inc. (ICVX)?

As of the latest market data, Icosavax, Inc. (ICVX) is trading at $15.31. The stock has seen a loss of -0.91% today.

Does Icosavax, Inc. (ICVX) pay a dividend?

Based on current data, Icosavax, Inc. does not have a confirmed active dividend policy.

What is the market cap of Icosavax, Inc.?

The current market capitalization of Icosavax, Inc. (ICVX) is approximately unavailable.

ICVX

Icosavax, Inc.·Healthcare

15.31

0.906%(−0.14)

Close Price

Last Updated: — ET

52W L: $4.7552W H: $16.11

Company Profile

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-07-29

Beta

1.28

Websiteicosavax.com↗